Reports, publications, and recordings | Medicines Discovery Catapult

Data Access Quick Guides – Access to the NIH Database of Genotypes and Phenotypes (dbGaP)

We have produced a series of Data Access Guides for a number of the major UK data suppliers that summarise the data they contain and how you might access it as an SME. The US National Institute of Health’s (NIH) National Center for Biotechnology Information (NCBI) is responsible for creating automated systems for storing and […]

Webinar – Connecting the Data Wires

Now more than ever, the need for establishing connections and closer collaboration is a priority for many organisations. Practical steps in establishing the areas for focus and priority isn’t as straight forward as it should initially seem to be. There is often a disconnect between the requirements and the provider solutions meaning that solutions, or […]

Webinar – Hit Identification

MDC Connects is a series of informative webinars covering the drug discovery process, from our own experts and experts at our CRO network partners. The identification of high quality leads is an important step in the discovery of a new drug, but in order to achieve a relevant starting point there are several factors to […]

Webinar – Identifying the Target

MDC Connects is a series of informative webinars covering the drug discovery process, from our own experts and experts at our CRO network partners. Lack of efficacy is one of the most important causes of failure in clinical trials. Therefore identifying the biological target for a drug discovery project is one of the most important […]

The Issue with Tissue

About 1 million patients have consented to their samples being used specifically in research studies. There are a further 3 to 5 million samples held in tissue banks in the UK, where patients have permitted their sample to be used in future studies. However, it has been estimated that only 15% of samples donated for research are ever used. […]

Webinar – Turning Molecules into Medicines

In this webinar, Gayle Marshall, Lead Scientist for Biomarkers, covers why drugs fail in the clinic and how to acquire critical information to inform confidence for clinical success. Gayle discusses how we can aid decision making from the pre-clinical to the clinical setting, supporting line of sight to the clinic, by identifying and translating crucial biomarker approaches […]

Use of health data by the life sciences industry: a UK perspective

This report explores the use of health data and the barriers faced by the UK life sciences industry. It highlights the tangible steps being taken by UK stakeholders to deliver a ‘clear, credible national offer’ for the R&D community, which would be in the public interest. It also highlights areas where further joint effort is needed for the UK to be globally competitive. The report was released in collaboration with the Association of […]

Webinar – Psychiatry Consortium first call for proposals

In this webinar Alessandra Gaeta, Programme Director, Syndicates, talks through the Psychiatry Consortium first call for proposals – including scope, eligibility and detail on the funding model. Recording Find out more about the Psychiatry Consortium >

Webinar – Imaging technologies to visualise drug discovery

Imaging allows a non-invasive assessment of biochemical and biological processes in a living subject. Monitoring, assessing, and characterising novel therapeutics in pre-clinical models is an essential part of drug development. In this webinar Dr Juliana Maynard, Lead Scientist in Pre-clinical Imaging, and Dr Philippa Hart, Lead Scientist in Mass Spectrometry Imaging, explore available imaging technologies […]

Older posts

Newer posts